Benuvia Operations Llc, based in U.S.A, is a pharmaceutical company.
One of their notable products is DRONABINOL USP, with a corresponding US DMF Number 19207.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 27, 2026, and payment made on January 19, 2026, indicating their dedication to facilitating drug approvals, Categorized as Type II